• Main Navigation
  • Account Navigation
  • Main Content
  • ASH Home
  • ASH Store
  • ASH Academy
  • My Cart
  • My Account
  • Sign in
  • Cookie Settings
 To purchase or access the 2020 Annual Meeting Webcasts, please click here
Show Main Menu+
  • About ASH On Demand
  • FAQs
  • Contact Us
  • Catalog
  • Annual Meetings
  • Meetings
    • Meeting on Hematologic Malignancies
    • Consultative Hematology Course
    • Highlights of ASH
    • Education Summaries
  • Free Content
    • Webinars
    • Videos
    • Podcasts
  • My Library
    Check Out
    Minimize
    Home / Videos

    ASH Impact Series: Ruben Mesa, MD - Examining the Current Role of Ruxolitinib in Myelofibrosis

    12/13/2016

    Description

    Ruben Mesa, MD, discusses ruxolitinib, the front-line therapy for patients with myelofibrosis, as well as whether combination therapy should be considered in myelofibrosis, and more. Dr. Mesa presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat Myelofibrosis Patients Who Have 'Failed' Ruxolitinib." Visit https://ashondemand.org/ for more on this topic and to watch other educational videos from ASH.

    Speakers

    • Ruben Mesa, MD

    back to top
    placeholder + image

    62nd ASH Virtual Annual Meeting

    December 5-8, 2020
    Virtual Experience

    Learn more
    placeholder + image

    ASH Meeting on Hematologic Malignancies

    Hear the latest developments in clinical care, and get answers to your most challenging patient care questions.

    Learn more

    AMERICAN SOCIETY OF HEMATOLOGY

    2021 L Street NW, Suite 900, Washington, DC 20036

    Phone 202-776-0544 | Fax 202-776-0545

    • ASH Home
    • Research
    • Education
    • Advocacy
    • Meetings
    • Publications
    • ASH Store
    • facebook
    • twitter
    • linkedin

    Copyright © 2021 by American Society of Hematology

    Privacy Policy |Terms of Service |Contact Us